BG Medicine, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2013
Net loss for the year ended December 31, 2013 was $15.85 million, or $0.58 loss per share, compared to a net loss of $23.77 million, or $1.18 loss per share, for the year ended December 31, 2012. Total revenues for the year ended December 31, 2013 were $4.07 million, compared to $2.81 million for the year ended December 31, 2012.